Estrogen receptors (ER_α versus ER_β): friends or foes in human biology?

References

• Muramatsu M, Inoue S. Estrogen receptors: how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun 2000;270:1–10
   PubMed Web of Science ®Google Scholar
• Lumachi F, Luisetto G, Basso SM, et al. Endocrine therapy of breast cancer. Curr Med Chem 2011;18:513–22
   PubMed Web of Science ®Google Scholar
• Nilsson S, Gustafsson JA. Estrogen receptors: therapies targeted to receptor subtypes. Clin Pharmacol Ther 2011;89:44–55
   PubMed Web of Science ®Google Scholar
• Gronemeyer H. Transcription activation by estrogen and progesterone receptors. Annu Rev Genet 1991;25:89–123
   PubMed Web of Science ®Google Scholar
• Kumar R, Thompson EB. The structure of the nuclear hormone receptors. Steroids 1999;64:310–9
   PubMed Web of Science ®Google Scholar
• Parker MG. Transcriptional activation by oestrogen receptors. Biochem Soc Symp 1998;63:45–50
   PubMedGoogle Scholar
• Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004;25:45–71
   PubMed Web of Science ®Google Scholar
• Karamouzis MV, Konstantinopoulos PA, Badra FA, Papavassiliou AG. SUMO and estrogen receptors in breast cancer. Breast Cancer Res Treat 2008;107:195–210
   PubMedGoogle Scholar
• Swedenborg E, Power KA, Cai W, et al. Regulation of estrogen receptor beta activity and implications in health and disease. Cell Mol Life Sci 2009;66:3873–94
   PubMed Web of Science ®Google Scholar
• Welboren WJ, Sweep FC, Span PN, Stunnenberg HG. Genomic actions of estrogen receptor alpha: what are the targets and how are they regulated? Endocr Relat Cancer 2009;16:1073–89
   PubMed Web of Science ®Google Scholar
• Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997;82:4258–65
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen BS, Korach KS. A new actor in the estrogen receptor drama–enter ER-beta. Endocrinology 1997;138:861–2
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863–70
   PubMed Web of Science ®Google Scholar
• Kuiper GG, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996;93:5925–30
   PubMed Web of Science ®Google Scholar
• Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 1996;392:49–53
   PubMed Web of Science ®Google Scholar
• Beato M, Herrlich P, Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995;83:851–7
   PubMed Web of Science ®Google Scholar
• Beato M. Gene regulation by steroid hormones. Cell 1989;56:335–44
   PubMed Web of Science ®Google Scholar
• Tora L, White J, Brou C, et al. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell 1989;59:477–87
   PubMed Web of Science ®Google Scholar
• Berry M, Metzger D, Chambon P. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 1990;9:2811–8
   PubMed Web of Science ®Google Scholar
• Montano MM, Muller V, Trobaugh A, Katzenellenbogen BS. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists. Mol Endocrinol 1995;9:814–25
   PubMedGoogle Scholar
• Koide A, Zhao C, Naganuma M, et al. Identification of regions within the F domain of the human estrogen receptor alpha that are important for modulating transactivation and protein-protein interactions. Mol Endocrinol 2007;21:829–42
   PubMedGoogle Scholar
• Yang J, Singleton DW, Shaughnessy EA, Khan SA. The F-domain of estrogen receptor-alpha inhibits ligand induced receptor dimerization. Mol Cell Endocrinol 2008;295:94–100
   PubMedGoogle Scholar
• Schwabe JW, Neuhaus D, Rhodes D. Solution structure of the DNA-binding domain of the oestrogen receptor. Nature 1990;348:458–61
   PubMed Web of Science ®Google Scholar
• Schwabe JW, Chapman L, Finch JT, Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 1993;75:567–78
   PubMed Web of Science ®Google Scholar
• Brzozowski AM, Pike AC, Dauter Z, et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997;389:753–8
   PubMed Web of Science ®Google Scholar
• Pike AC, Brzozowski AM, Hubbard RE, et al. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999;18:4608–18
   PubMed Web of Science ®Google Scholar
• Kong EH, Heldring N, Gustafsson JA, et al. Delineation of a unique protein-protein interaction site on the surface of the estrogen receptor. Proc Natl Acad Sci U S A 2005;102:3593–8
   PubMed Web of Science ®Google Scholar
• Tanenbaum DM, Wang Y, Williams SP, Sigler PB. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci U S A 1998;95:5998–6003
   PubMed Web of Science ®Google Scholar
• Celik L, Lund JD, Schiott B. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics. Biochemistry 2007;46:1743–58
   PubMedGoogle Scholar
• Anstead GM, Carlson KE, Katzenellenbogen JA. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 1997;62:268–303
   PubMed Web of Science ®Google Scholar
• Shiau AK, Barstad D, Loria PM, et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998;95:927–37
   PubMed Web of Science ®Google Scholar
• Katzenellenbogen BS, Choi I, Delage-Mourroux R, et al. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 2000;74:279–85
   PubMed Web of Science ®Google Scholar
• Sun J, Meyers MJ, Fink BE, et al. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology 1999;140:800–4
   PubMed Web of Science ®Google Scholar
• Edsall RJ Jr, Harris HA, Manas ES, Mewshaw RE. ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template. Bioorg Med Chem 2003;11:3457–74
   PubMed Web of Science ®Google Scholar
• Shang Y. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 2006;6:360–8
   PubMed Web of Science ®Google Scholar
• Warnmark A, Wikstrom A, Wright AP, et al. The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties. J Biol Chem 2001;276:45939–44
   PubMedGoogle Scholar
• Kumar R, Lee JC, Bolen DW, Thompson EB. The conformation of the glucocorticoid receptor af1/tau1 domain induced by osmolyte binds co-regulatory proteins. J Biol Chem 2001;276:18146–52
   PubMedGoogle Scholar
• Kumar R, Thompson EB. Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions. Mol Endocrinol 2003;17:1–10
   PubMedGoogle Scholar
• Compston JE. Selective oestrogen receptor modulators: potential therapeutic applications. Clin Endocrinol (Oxf) 1998;48:389–91
   PubMedGoogle Scholar
• Gustafsson JA. Therapeutic potential of selective estrogen receptor modulators. Curr Opin Chem Biol 1998;2:508–11
   PubMedGoogle Scholar
• Suen CS, Berrodin TJ, Mastroeni R, et al. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J Biol Chem 1998;273:27645–53
   PubMedGoogle Scholar
• Tremblay A, Tremblay GB, Labrie F, Giguere V. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell 1999;3:513–9
   PubMed Web of Science ®Google Scholar
• Anzick SL, Kononen J, Walker RL, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 1997;277:965–8
   PubMed Web of Science ®Google Scholar
• Krege JH, Hodgin JB, Couse JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998;95:15677–82
   PubMed Web of Science ®Google Scholar
• Warner M, Nilsson S, Gustafsson JA. The estrogen receptor family. Curr Opin Obstet Gynecol 1999;11:249–54
   PubMed Web of Science ®Google Scholar
• Nilsson S, Koehler KF, Gustafsson JA. Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov 2011;10:778–92
   PubMed Web of Science ®Google Scholar
• Nilsson S, Makela S, Treuter E, et al. Mechanisms of estrogen action. Physiol Rev 2001;81:1535–65
   PubMed Web of Science ®Google Scholar
• Turner RT. Mice, estrogen, and postmenopausal osteoporosis. J Bone Miner Res 1999;14:187–91
   PubMedGoogle Scholar
• Turner RT, Wakley GK, Hannon KS. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J Orthop Res 1990;8:612–7
   PubMed Web of Science ®Google Scholar
• Onoe Y, Miyaura C, Ohta H, et al. Expression of estrogen receptor beta in rat bone. Endocrinology 1997;138:4509–12
   PubMed Web of Science ®Google Scholar
• Oreffo RO, Kusec V, Virdi AS, et al. Expression of estrogen receptor-alpha in cells of the osteoclastic lineage. Histochem Cell Biol 1999;111:125–33
   PubMedGoogle Scholar
• Kusec V, Virdi AS, Prince R, Triffitt JT. Localization of estrogen receptor-alpha in human and rabbit skeletal tissues. J Clin Endocrinol Metab 1998;83:2421–8
   PubMed Web of Science ®Google Scholar
• Nilsson LO, Boman A, Savendahl L, et al. Demonstration of estrogen receptor-beta immunoreactivity in human growth plate cartilage. J Clin Endocrinol Metab 1999;84:370–3
   PubMed Web of Science ®Google Scholar
• Vidal O, Kindblom LG, Ohlsson C. Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res 1999;14:923–9
   PubMed Web of Science ®Google Scholar
• Shapiro DJ, Mao C, Cherian MT. Small molecule inhibitors as probes for estrogen and androgen receptor action. J Biol Chem 2011;286:4043–8
   PubMed Web of Science ®Google Scholar
• Robertson JF. Fulvestrant (Faslodex®) – How to make a good drug better. Oncologist 2007;12:774–84
   PubMed Web of Science ®Google Scholar
• Lonard DM, O’Malley BW. Nuclear receptor coregulators: modulators of pathology and therapeutic targets. Nat Rev Endocrinol 2012;8:598–604
   PubMed Web of Science ®Google Scholar
• Nilsson S, Koehler KF, Gustafsson JÅ. Development of subtype-selective oestrogen receptor-based therapeutics. Nat Rev Drug Discov 2011;10:778–92
   PubMed Web of Science ®Google Scholar